MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/neuonc/noad097

Медицинская библиотека · Neuro-oncology · 2023

Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.

Larsson Alex T, Bhatia Himanshi, Calizo Ana, Pollard Kai, Zhang Xiaochun, Conniff Eric, Tibbitts Justin F, Rono Elizabeth, Cummins Katherine, Osum Sara H, Williams Kyle B, Crampton Alexandra L, Jubenville Tyler, Schefer Daniel, Yang Kuangying, Lyu Yang, Pino James C, Bade Jessica, Gross John M, Lisok Alla, Dehner Carina A, Chrisinger John S A, He Kevin, Gosline Sara J C, Pratilas Christine A, Largaespada David A, Wood David K, Hirbe Angela C

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft tissue sarcomas that often develop in patients with neurofibromatosis type 1 (NF1). To address the critical need for novel therapeutics in MPNST, we aimed to establish an ex vivo 3D platform that accurately captured the genomic diversity of MPNST and could be utilized in a medium-throughput manner for drug screening studies to be validated in vivo using patient-derived xenografts (PDX).

METHODS

Genomic analysis was performed on all PDX-tumor pairs. Selected PDX were harvested for assembly into 3D microtissues. Based on prior work in our labs, we evaluated drugs (trabectedin, olaparib, and mirdametinib) ex vivo and in vivo. For 3D microtissue studies, cell viability was the endpoint as assessed by Zeiss Axio Observer. For PDX drug studies, tumor volume was measured twice weekly. Bulk RNA sequencing was performed to identify pathways enriched in cells.

RESULTS

We developed 13 NF1-associated MPNST-PDX and identified mutations or structural abnormalities in NF1 (100%), SUZ12 (85%), EED (15%), TP53 (15%), CDKN2A (85%), and chromosome 8 gain (77%). We successfully assembled PDX into 3D microtissues, categorized as robust (>90% viability at 48 h), good (>50%), or unusable (<50%). We evaluated drug response to "robust" or "good" microtissues, namely MN-2, JH-2-002, JH-2-079-c, and WU-225. Drug response ex vivo predicted drug response in vivo, and enhanced drug effects were observed in select models.

CONCLUSIONS

These data support the successful establishment of a novel 3D platform for drug discovery and MPNST biology exploration in a system representative of the human condition.

Для цитирования: Larsson Alex T, Bhatia Himanshi, Calizo Ana, Pollard Kai, Zhang Xiaochun, Conniff Eric, Tibbitts Justin F, Rono Elizabeth, Cummins Katherine, Osum Sara H, Williams Kyle B, Crampton Alexandra L, Jubenville Tyler, Schefer Daniel, Yang Kuangying, Lyu Yang, Pino James C, Bade Jessica, Gross John M, Lisok Alla, Dehner Carina A, Chrisinger John S A, He Kevin, Gosline Sara J C, Pratilas Christine A, Largaespada David A, Wood David K, Hirbe Angela C. Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.. Neuro-oncology. 2023. DOI: 10.1093/neuonc/noad097.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.